An Act to Limit Hypodermic Apparatus Exchange Programs to a One-for-one Exchange
Summary
LD 219 proposes to change Maine law governing certified hypodermic apparatus exchange programs by requiring a strict one-for-one exchange. Under the bill, the Maine Center for Disease Control and Prevention would be directed to limit the number of hypodermic apparatuses provided to a participant to one for each used apparatus that participant turns in. The measure amends existing law to make this limitation mandatory rather than discretionary.
The bill is aimed at syringe and needle exchange programs, which are part of the state’s public health response to injection drug use and disease prevention. By tying distribution directly to returned used equipment, the bill would narrow the current flexibility of these programs and could reduce the number of sterile syringes available to participants who do not have used apparatuses to exchange. It would affect certified exchange programs and the state agency that oversees them, the Maine CDC.
Impact
If enacted, LD 219 would amend Maine’s statutes governing hypodermic apparatus exchange programs to require a one-for-one exchange model. This would constrain the Maine Center for Disease Control and Prevention’s authority and change how certified programs distribute syringes and related equipment to participants. The practical effect would be to alter harm-reduction operations statewide and potentially affect public health, overdose-prevention, and infectious-disease prevention efforts.
Sentiment
The recorded voting history indicates the bill faced significant opposition. The House first adopted a majority ought-not-to-pass report by a narrow margin, and the Senate later accepted that majority report. That pattern suggests the prevailing sentiment in the Legislature was against advancing the bill, likely reflecting concern about restricting syringe access in harm-reduction programs.
Contention
The central point of contention is whether hypodermic apparatus exchange programs should be limited to strict one-for-one distribution. Supporters of the bill likely view the requirement as a way to ensure exchanges remain tightly controlled, while opponents likely see it as undermining public health goals by making sterile syringes less accessible to people who need them. The debate appears to have centered on balancing harm reduction and disease prevention against concerns about the scope and operation of syringe exchange programs.